Normal Saline Infusion for Stroke After Intravenous Thrombolysis

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 241 participants.

Also called NCT05993078

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 241 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05993078
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05993078. Randomized; double masking; primary purpose treatment. Start 2023-09-01 (actual); primary completion 2024-12-20 (actual). Results posted on 2025-03-12.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Normal Saline Infusion for Stroke After Intravenous Thrombolysis
Acronym
NS-STAR
Condition
Brain Infarct
Intervention (Drug)
0.9% NaCl 2000ml
Intervention (Drug)
0.9% NaCl 200-400ml
Lead sponsor
Tianjin Medical University General Hospital (class: other)
Collaborator
Affliated Hospital of Jiujiang University (class: not stated)
Collaborator
Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine (class: other)

Record details

Record id
cardio:ct-nct05993078
Content hash
50f659c79c01e68b67ca35f475b1186bac0b9646f9487d478b6418abbfc42b43